Insurers and pharma alike oppose two Trump drug pricing proposals

Insurers and pharma alike oppose two Trump drug pricing proposals

STAT Plus: Insurers, drug makers, and patient advocates blast two Trump proposals to drive down drug prices

By NICHOLAS FLORKO

ADOBE

Nearly every corner of the health industry voiced its opposition to two Trump proposals that aim to promote generic and biosimilar medications.

READ MORE